Literature DB >> 18504161

The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.

Hyoun-Ah Kim1, Ja-Young Jeon, Gil-Soon Choi, Jun-Mo Sung, Moo-Jung Kim, Jeong-Moon Yun, Chang-Hee Suh.   

Abstract

We have investigated the clinical utility of antichromatin antibodies for the diagnosis of SLE and as a marker of disease activity in Korean SLE patients. Blood samples were collected from SLE patients, lupus syndrome patients having only two or three of ACR classification criteria for SLE and normal controls. The level of antichromatin antibody was measured by enzyme linked immunosorbent assay and expressed as arbitrary unit. The antichromatin antibody levels of the SLE and lupus syndrome patients were higher than NC. The antichromatin antibody levels were significant higher in SLE patients with arthritis. A significant correlation was found between the level of antichromatin antibodies and each of anti-dsDNA antibody, leukopenia, complement and SLEDAI. The change of antichromatin antibody levels showed a positive correlation with the change of SLEDAI in serial samples. These data suggest that the antichromatin antibodies appear to be a useful laboratory test that can help in the diagnosis and assessment of SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504161     DOI: 10.1016/j.clim.2008.03.516

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Ja-Young Jeon; Jeong-Moon Yoon; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

2.  Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population.

Authors:  G A Sardeto; L M Simas; T S Skare; R M Nisihara; S R R Utiyama
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

3.  Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.

Authors:  Yanli Zeng; Yiqiang Lin; Xuelian Wang; Yan Zhang; Feng Peng; JiaJia Wang; Longcan Jiang; Shiqiong Liang; Yun Xiao
Journal:  Clin Rheumatol       Date:  2020-03-18       Impact factor: 2.980

Review 4.  Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.

Authors:  Ju-Yang Jung; Chang-Hee Suh
Journal:  Korean J Intern Med       Date:  2017-04-28       Impact factor: 2.884

5.  Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.

Authors:  Yanli Zeng; Qiaoduan Lin; Liang Yu; Xuelian Wang; Yiqiang Lin; Yan Zhang; Shuidi Yan; Xinxin Lu; Yijing Li; Weibin Li; Yun Xiao
Journal:  BMC Immunol       Date:  2021-12-27       Impact factor: 3.615

6.  Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study.

Authors:  Ju-Yang Jung; Jin-Young Nam; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 7.  The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.

Authors:  Sonal Mehra; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-03       Impact factor: 4.818

8.  High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction.

Authors:  Rodrigo C Oliveira; Isabela S Oliveira; Mittermayer B Santiago; Maria L B Sousa Atta; Ajax M Atta
Journal:  J Immunol Res       Date:  2015-10-25       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.